You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

June 29, 2015

The International Comparative Legal Guide to: Pharmaceutical Advertising 2015 – Vietnam Chapter

Global Legal Group

Kien Trung Trinh, senior attorney-at-law, and Tu Ngoc Trinh, attorney-at-law, in Tilleke & Gibbins’ Hanoi office, have co-authored the Vietnam chapter of The International Comparative Legal Guide to: Pharmaceutical Advertising 2015 (12th edition), a Q&A-style guide that provides practical, cross-border insight into pharmaceutical advertising across 35 jurisdictions. The Vietnam chapter covers the following main topics:

  • Medicinal Products in General: Laws and codes of practice, definition of “advertising,” company compliance arrangements, standard operating procedures, regulatory or industry authority approval, penalties for noncompliance, relationship between self-regulatory processes and function of competent authorities, and unfair competition.
  • Providing Information Prior to Authorization of Medicinal Products: Making information available to healthcare professionals before a medicinal product is authorized, publishing information on unauthorized medicines and/or off-label information, and using healthcare professionals in market research exercises concerning possible launch materials for medicinal products that are unauthorized.
  • Advertisements to Healthcare Professionals: Advertisement requirements and restrictions, rules governing comparative advertisements, rules governing the distribution of scientific papers and/or proceedings of congresses to healthcare professionals, and “teaser” advertisements.
  • Gifts and Financial Incentives: Providing medicinal product samples to healthcare professionals, giving gifts or donations, volume-related discounts, refund schemes, and sponsoring medical education.
  • Hospitality and Related Payments: Offering hospitality to healthcare professionals and paying healthcare professionals to provide expert services and take part in post-marketing surveillance studies and market research involving promotional materials.
  • Advertising to the General Public: Advertising prescription-only and nonprescription medicines, press releases, describing products and research initiatives as background information in corporate brochures and annual reports, and meetings with and funding of patent organizations.
  • Transparency and Disclosure: Obligations to disclose details of ongoing and/or completed clinical trials and requirements to make information public.
  • The Internet: Regulations, website security, content of independent websites that may be accessed by a link from a company-sponsored site, permitted information on pharmaceutical company websites, and social media.
  • Developments in Pharmaceutical Advertising: Significant developments and general practice or enforcement trends.

The ICLG series, published by the Global Legal Group, provides multi-jurisdictional insight into a range of legal areas.

This article appeared in the 2015 edition of The International Comparative Legal Guide to: Pharmaceutical Advertising; published by Global Legal Group Ltd, London. (www.iclg.co.uk )

RELATED INSIGHTS​